CDK1 and retinoblastoma: In this study, we evaluated TOP2A and CDK1—two most differentially expressed genes within the retinoblastoma pathway that also demonstrated high predictive accuracy in machine learning-based classification— as potential biomarkers using immunohistochemistry.